TRAINING OF ACADEMIC UROLOGIC ONCOLOGIST

描述（申请人的描述）：T32培训的主要目标 获得德克萨斯大学泌尿外科医学博士学位。安德森 癌症中心是培养学术泌尿肿瘤学家。部 在培养年轻的医学科学家方面有着出色的记录， 在美国的主要学术课程中承担责任。在 此外，该部还培养了高素质的研究科学家， 继续进行泌尿科调查。该计划致力于提供 为代表性不足的少数群体提供研究机会。 此 培训补助金中的导师（医生-科学家和研究人员） 拥有由外部同行支持的活跃研究实验室的科学家， 审查资金）致力于以高质量的研究经验为重点 泌尿系统癌症 在肿瘤治疗中， 生物学，癌基因和肿瘤抑制基因调节，化学预防， 信号转导和其他癌症相关的研究领域。实验室 经验还得到许多其他教育机会的补充。 培训主要提供给已经完成泌尿外科手术的医生。 住院医师，并致力于学术泌尿学的职业生涯和三年的 培训（2年由培训补助金支助的实验室研究， 临床培训）。 一个额外的培训机会是一个职位- 博士奖学金包括两年的研究。大学 德克萨斯医学博士 安德森癌症中心大力推动核心使命， 卓越的研究，教育和病人护理。T32培训补助金 使这个激励的学术环境提供给有抱负的医生 和科学家，并为他们发展成为领导者提供了一个框架， 学术泌尿肿瘤学

DESCRIPTION (Applicant's Description): The primary goal of the T32 training grant in the Department of Urology of the University of Texas M.D. Anderson Cancer Center is to produce academic urological oncologists. The Department has an excellent record of producing young physician-scientists with positions of responsibility in major academic programs in the United States. In addition, the Department has developed high quality research scientists who have continued in urologic investigation. The program is committed to provide research opportunities to individuals of underrepresented minorities. T h e mentors in this training grant(physician-scientists and research scientists with active research laboratories supported by external peer- reviewed funding) are committed to a high quality research experience focused on urologic cancer. A broad range of opportunities is available in tumor biology, oncogene and tumor suppressor gene modulation, chemoprevention, signal transduction, and other cancer-related research areas. The laboratory experience is supplemented by numerous other educational opportunities. Training is primarily offered to physicians who have completed a urological residency and are committed to a career in academic urology and three years of training (2 years of laboratory research supported by the training grant and 1 year of clinical training). An additional training opportunity is a post- doctoral fellowship consisting of two years of research. The University of Texas M.D. Anderson Cancer Center vigorously promotes a core mission of excellence in research, education, and patient care. The T32 training grant makes this stimulating academic environment available to aspiring physicians and scientists and provides a framework for their development into leaders in academic urologic oncology.